Premium
Risk of severe allergic reactions to COVID‐19 vaccines among patients with allergic skin diseases – practical recommendations. A position statement of ETFAD with external experts
Author(s) -
Ring J.,
Worm M.,
Wollenberg A.,
Thyssen J.P.,
Jakob T.,
Klimek L.,
Bangert C.,
Barbarot S.,
Bieber T.,
BruinWeller M.S.,
Chernyshov P.V.,
ChristenZaech S.,
Cork M.,
Darsow U.,
Flohr C.,
FölsterHolst R.,
Gelmetti C.,
Gieler U.,
Gutermuth J.,
Heratizadeh A.,
Hijnen D.J.,
Kobyletzki L.B.,
Kunz B.,
Paul C.,
De Raeve L.,
Seneschal J.,
Simon D.,
Spuls P.I.,
Stalder J.F.,
Svensson A.,
Szalai Z.,
Taieb A.,
Torrelo A.,
Trzeciak M.,
Vestergaard C.,
Werfel T.,
Weidinger S.,
Deleuran M.
Publication year - 2021
Publication title -
journal of the european academy of dermatology and venereology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.655
H-Index - 107
eISSN - 1468-3083
pISSN - 0926-9959
DOI - 10.1111/jdv.17237
Subject(s) - venereology , atopic dermatitis , medicine , dermatology , covid-19 , university hospital , allergy , family medicine , immunology , pathology , disease , infectious disease (medical specialty)